Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Cinnarizine Calcium Channel Vasodilation Action Pathway
Homo sapiens
Drug Action Pathway
Cinnarizine is a drug used for the management of labyrinthine disorder symptoms, including vertigo, tinnitus, nystagmus, nausea, and vomiting. Cinnarizine could be also viewed as a nootropic drug because of its vasorelaxating abilities (due to calcium channel blockage), which happen mostly in brain. Combination use of cinnarizine with other nootropics, such as piracetam resulted in enhanced effect of boosting brain oxygen supply. Cinnarizine is an antihistamine and a calcium channel blocker. Cinnarizine inhibits contractions of vascular smooth muscle cells by blocking L-type and T-type voltage gated calcium channels. By blocking the entrance of extracellular calcium into the cell, it prevents smooth muscle contraction. This produces vasodilation which decreases blood pressure. Side effects experienced while taking cinnarizine range from the mild to the quite severe. Possible side effects include drowsiness, sweating, dry mouth, headache, skin problems, lethargy, gastrointestinal irritation, hypersensitivity reactions, as well as movement problems/muscle rigidity, and tremor.
References
Cinnarizine Calcium Channel Vasodilation Pathway References
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Kirtane MV, Bhandari A, Narang P, Santani R: Cinnarizine: A Contemporary Review. Indian J Otolaryngol Head Neck Surg. 2019 Nov;71(Suppl 2):1060-1068. doi: 10.1007/s12070-017-1120-7. Epub 2017 Apr 25.
Pubmed: 31750127
Castaneda-Hernandez G, Vargas-Alvarado Y, Aguirre F, Flores-Murrieta FJ: Pharmacokinetics of cinnarizine after single and multiple dosing in healthy volunteers. Arzneimittelforschung. 1993 May;43(5):539-42.
Pubmed: 8328998
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings